Please go ahead, sir. Thank you, operator. Good morning, everyone. And welcome to PDS Biotech's 2024 results and clinical program update call. I am joined on the call today by the following ...

Full Year 2024 Financial Results Net loss for the year ended December ... and Section 27A of the United States Securities Act of 1933, as amended) concerning PDS Biotechnology Corporation (the ...

Good morning and welcome to PDS Biotech's 4th quarter in full year 2024 earnings conference call. Thank you, operator. Good morning, everyone, and welcome to PDS Biotech's 2024 results and ...

THE PHILIPPINE Stock Exchange, Inc. (PSE) has increased its stake in Philippine Dealing System Holdings Corp. (PDS) to 83.04% after closing a share purchase deal with financial advisory company ...

About PDS BiotechnologyPDS Biotechnology is a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers. The Company has initiated a pivotal clinical ...

Those factors aside, it said ongoing and planned infrastructure projects and refinancing for large maturities valued at RM96.2bil should also spur PDS issuance in 2024. A gross issuance is the ...

Q4 2024 Earnings Call Transcript March 27, 2025 PDS Biotechnology Corporation beats earnings expectations. Reported EPS is $-0.21, expectations were $-0.29. Operator: Good morning. And welcome to PDS ...

PRINCETON, N.J., March 27, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq ... results for the full year ended December 31, 2024. “We are pleased with the progress made over ...

After the live webcast, the event will be archived on PDS Biotech’s website for six months. About PDS Biotechnology PDS Biotechnology is a late-stage immunotherapy company focused on ...